The single remaining monoclonal antibody therapy effective against the variant is now in short supply in the U.S., imperiling an option that doctors and hospitals have relied on.
Source: New York Times
Hospitals Scramble as Antibody Treatments Fail Against Omicron
Published in Antibodies, Coronavirus Omicron Variant and Hospitals
More from AntibodiesMore posts in Antibodies »
More from Coronavirus Omicron VariantMore posts in Coronavirus Omicron Variant »
- New Covid Booster Shots Cut Risk of Hospitalization by Half, CDC Reports
- Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.
- Covid, Flu and RSV Are Increasing Hospitalizations in NYC
- Paxlovid Cuts Covid Deaths Among Older People, Israeli Study Finds
- Hochul says N.Y. students probably won’t have to mask, but keeps a public transit mandate.
More from HospitalsMore posts in Hospitals »
- Northwell Health Is Starting Its Own Film Studio After Starring in Documentaries
- Brooklyn Hospital Network Battles a Cyberattack
- NYC Will Hospitalize Mentally Ill People Involuntarily
- Covid Almost Broke This Hospital. It Also Might Be What Saves It.
- As the Pandemic Drags On, Americans Struggle for New Balance
Be First to Comment